Innomedica is currently running
The new flu vaccine trial will start in Innomedica in the fall of 2023.
The vaccine under study is a new technology. The purpose of the study is to evaluate the immune response (i.e. the body’s response) and safety of the new vaccine compared to the current flu vaccine.
To get more information about the study, call us at 6109434 or fill out the form below and we will contact you.
I would like more information.
During the examination, a team of doctors and nurses will closely monitor your health. All study drugs and analyzes related to the study are free for you. Participation in the study is unpaid, but you may be reimbursed for travel expenses incurred during participation.
Participation in the study is voluntary. Contacting us does not obligate you to participate in the study.
*The study has been coordinated with the Human Research Ethics Committee of the Health Development Institute and the Medicines Agency. Regulation No. 23 of the Minister of Social Affairs of 17.02.2005 “Procedure and execution of a clinical trial of a medicinal product” obliges to inform that “it is a scientific study that may involve a risk to the participant’s health”.
